University of Cambridge

Sequencing genome breakthrough

Whole-genome sequencing has allowed researchers all over the world to investigate DNA at a scale and depth that was unimaginable just a generation ago.

Solexa sequencing – developed by scientists at the University of Cambridge – is one of a number of next-generation sequencing methods which has helped develop new treatments for disease, and revealed the evolutionary history of life on Earth.

Born from a pub conversation in 1997, the Solexa team sequenced their first genome in 2005, launched its first sequencer in 2006, and in 2007 was acquired by US-based company Illumina for $650 million.

Further reading